What is the Historic and Current Scenario of the Metagenomics Market?
The metagenomics market has seen considerable growth due to a variety of factors.
•In recent times, there's been a swift expansion in the size of the metagenomics market. The market witnessed a significant rise from $2.01 billion in 2024 to $2.32 billion in 2025, calculating an annual growth rate (CAGR) of 15.4%.
The growth during the historical period can be credited to advancements in microbiome research, studies related to disease association, requirements for environmental monitoring, applications in agriculture and food, as well as biotechnology and industrial processes.
What are the Forecasted Growth and Key Factors of the Metagenomics Market?
The metagenomics market is expected to maintain its strong growth trajectory in upcoming years.
• The size of the metagenomics market is predicted to experience swift expansion in the coming years. It is forecasted to hit "$4 billion by 2029 with a compound annual growth rate (CAGR) of 14.7%.
The projected increase during this period can be attributed to factors such as integration of precision medicine, understanding of microbial ecology, one health initiatives, bioprospecting and drug discovery, and innovation in diagnostics and therapeutics. Key trends during the projected period include advancements in sequencing technology, incorporation of artificial intelligence and machine learning, single-cell metagenomics, standardization of metagenomic data, and focus on consumer wellness and personalized nutrition.
What Are The Leading Drivers Of Growth In The Metagenomics Market?
The escalating occurrence of infectious diseases is playing a significant role in propelling the expansion of the metagenomics market. Infectious diseases, or transmissible diseases, are illnesses instigated by pathogenic microorganisms - bacteria, viruses, fungi, and parasites. They can be spread from one individual to another or through different transmission pathways. Metagenomics is applied to explore infectious diseases by assessing the genetic content of microbial ecosystems. This enables a comprehensive examination of microbial communities correlated with infectious agents, yielding knowledge about their structure, genetic variability, and prospective interactions. For example, as per a report published by the UK Health Security Agency, a UK government agency, in February 2024, there was a 10.7% hike in tuberculosis (TB) cases in England in 2023, counting 4,850 cases compared to 4,380 in 2022. Consequently, the growing occurrence of infectious diseases is fueling the expansion of the metagenomics market.
How Are The Segments Defined Within The Global Metagenomics Market?
The metagenomics market covered in this report is segmented –
1) By Product: Instruments, Kits And Reagents, Software And Services
2) By Workflow: Sequencing, Pre-Sequencing, Data Analysis
3) By Application: Environmental, Clinical Diagnostics, Drug Discovery, Biotechnology, Food And Nutrition, Other Applications
4) By End User: Pharmaceutical Industries, Research Laboratories, Biotechnology Companies, Pathology Laboratories, Academic And Research Institutes
Subsegments:
1) By Instruments: DNA Sequencers, PCR Machines, Microarray Systems, Mass Spectrometers
2) By Kits And Reagents: DNA Extraction Kits, Library Preparation Kits, Amplification Kits, Sequencing Reagents
3) By Software And Services: Data Analysis Software, Bioinformatics Services, Cloud-Based Data Storage, Consultation Services
Pre-Book The Metagenomics Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Expected To Influence The Growth Of The Metagenomics Market?
The metagenomics market is increasingly being driven by advancements in technology. The adoption of new genomics technologies by leading companies in the market, including CD Genomics, is aimed at enhancing their research capabilities and maintaining market dominance. For example, CD Genomics, a genomics services firm based in the U.S., introduced the Long-Read Metagenomic Sequencing service in May 2023. This cutting-edge technology equips researchers and scientists with superior understanding about the intricacy of microbial communities with unrivalled precision and profundity. CD Genomics' state-of-the-art technology and genomic knowledge enable customers to embark on a new journey of metagenomics research. Its core features, such as improved resolution, species identification, functional annotation, and comparative analysis are set to revolutionize metagenomics research by providing insights into microbial communities that were previously impossible to obtain.
Who Are the Key Players in the Metagenomics Market?
Major companies operating in the metagenomics market include:
• Illumina Inc.
• Promega Corporation
• Qiagen N.V.
• Thermo Fisher Scientific Inc.
• Perkin Elmer Inc.
• Bio-Rad Laboratories Inc.
• F. Hoffmann-La Roche Ltd.
• Novogene Co. Ltd.
• Oxford Nanopore Technologies Limited
• BGI Group
• Eurofins Scientific SE
• Arc Bio LLC
• Computomics GmbH
• Enterome Bioscience
• TAKARA BIO INC.
• Danaher Corporation
• ELITechGroup
• Metagenomi
• Cosmosid Inc.
• Pattern Ag
• Tiny Health
• MATIS OHF
• Adapsyn Bioscience
• Precidiag Inc.
• One Codex Inc.
• MetaBi Inc.
• Zymo Research Corporation
• Bluebee Holding BV
• Maverix Biomics Inc.
• Lucigen Corporation
What Is The Most Dominant Region In The Metagenomics Market?
North America was the largest region in the global metagenomics market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metagenomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
